Literature DB >> 15872281

Prevalence of derepressed ampC mutants and extended-spectrum beta-lactamase producers among clinical isolates of Citrobacter freundii, Enterobacter spp., and Serratia marcescens in Korea: dissemination of CTX-M-3, TEM-52, and SHV-12.

Jungmin Kim1, Yu-Mi Lim.   

Abstract

The resistance mechanism of extended-spectrum cephalosporins in clinical isolates of Citrobacter freundii, Enterobacter spp., and Serratia marcescens was studied. Of 152 isolates, 45 isolates (29.6%) were derepressed AmpC mutants and 39 isolates (25.7%) produced extended-spectrum beta-lactamase (ESBLs). The most prevalent ESBLs were CTX-M enzymes, followed by TEM-52 and SHV-12.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15872281      PMCID： PMC1153749          DOI： 10.1128/JCM.43.5.2452-2455.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  16 in total

1.  A 1998 survey of extended-spectrum beta-lactamases in Enterobacteriaceae in France. The French Study Group.

Authors:  C De Champs; D Sirot; C Chanal; R Bonnet; J Sirot
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

2.  Countrywide spread of CTX-M-3 extended-spectrum beta-lactamase-producing microorganisms of the family Enterobacteriaceae in Poland.

Authors:  Anna Baraniak; Janusz Fiett; Agnieszka Sulikowska; Waleria Hryniewicz; Marek Gniadkowski
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

3.  Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People's Republic of China.

Authors:  Aroonwadee Chanawong; Fatima Hannachi M'Zali; John Heritage; Jian-Hui Xiong; Peter Michael Hawkey
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

4.  Detection of beta-lactamase-mediated resistance.

Authors:  D M Livermore; D F Brown
Journal:  J Antimicrob Chemother       Date:  2001-07       Impact factor: 5.790

5.  High prevalence of extended-spectrum beta-lactamase-producing strains among blood isolates of Enterobacter spp. collected in a tertiary hospital during an 8-year period and their antimicrobial susceptibility patterns.

Authors:  Hyunjoo Pai; Jung Yun Hong; Jeong-Hum Byeon; Yun-Kyung Kim; Hoan-Jong Lee
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

6.  The use of analytical isoelectric focusing for detection and identification of beta-lactamases.

Authors:  A Mathew; A M Harris; M J Marshall; G W Ross
Journal:  J Gen Microbiol       Date:  1975-05

Review 7.  Present situation of antimicrobial resistance in Korea.

Authors:  Y Chong; K Lee
Journal:  J Infect Chemother       Date:  2000-12       Impact factor: 2.211

8.  Epidemiology of extended-spectrum beta-lactamase-producing Enterobacter isolates in a Spanish hospital during a 12-year period.

Authors:  Rafael Cantón; Antonio Oliver; Teresa M Coque; María del Carmen Varela; José Claudio Pérez-Díaz; Fernando Baquero
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

Review 9.  Extended-spectrum beta-lactamases: the European experience.

Authors:  D L Paterson
Journal:  Curr Opin Infect Dis       Date:  2001-12       Impact factor: 4.915

10.  Molecular epidemiology of Serratia marcescens in two hospitals in Gdańsk, Poland, over a 5-year period.

Authors:  Lukasz Naumiuk; Anna Baraniak; Marek Gniadkowski; Beata Krawczyk; Bartosz Rybak; Ewa Sadowy; Alfred Samet; Józef Kur
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948
View more
  16 in total

1.  Ciprofloxacin-resistant enterobacteria harboring the aac(6')-Ib-cr variant isolated from feces of inpatients in an intensive care unit in Uruguay.

Authors:  Nicolás F Cordeiro; Luciana Robino; Julio Medina; Verónica Seija; Inés Bado; Virginia García; Maximiliano Berro; Julio Pontet; Lucía López; Cristina Bazet; Gloria Rieppi; Gabriel Gutkind; Juan A Ayala; Rafael Vignoli
Journal:  Antimicrob Agents Chemother       Date:  2007-11-12       Impact factor: 5.191

2.  Plasmid-mediated quinolone resistance determinants qnrA, qnrB, and qnrS among clinical isolates of Enterobacteriaceae in a Korean hospital.

Authors:  Migma Dorji Tamang; Sung Yong Seol; Jae-Young Oh; Hee Young Kang; Je Chul Lee; Yoo Chul Lee; Dong Taek Cho; Jungmin Kim
Journal:  Antimicrob Agents Chemother       Date:  2008-08-25       Impact factor: 5.191

3.  Frequent detection of plasmid-mediated quinolone resistance (qnr) genes in multidrug-resistant Enterobacteriaceae blood isolates, Hong Kong.

Authors:  C C Lee; G Lui; M Ip; T K W Ling; N Lee
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-06-29       Impact factor: 3.267

4.  In Vitro Activity of Ceftolozane-Tazobactam against Enterobacter cloacae Complex Clinical Isolates with Different β-Lactam Resistance Phenotypes.

Authors:  Frédéric Robin; Michel Auzou; Richard Bonnet; Romain Lebreuilly; Christophe Isnard; Vincent Cattoir; François Guérin
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

5.  Citrobacter spp. simultaneously harboring blaCTX-M, blaTEM, blaSHV, blaampC, and insertion sequences IS26 and orf513: an evolutionary phenomenon of recent concern for antibiotic resistance.

Authors:  M Shahid
Journal:  J Clin Microbiol       Date:  2010-03-10       Impact factor: 5.948

Review 6.  Serratia infections: from military experiments to current practice.

Authors:  Steven D Mahlen
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

7.  Prevalence of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme among Enterobacteriaceae blood isolates in Korea.

Authors:  Eun Sil Kim; Jin-Yong Jeong; Jae-Bum Jun; Sang-Ho Choi; Sang-Oh Lee; Mi-Na Kim; Jun Hee Woo; Yang Soo Kim
Journal:  Antimicrob Agents Chemother       Date:  2009-03-16       Impact factor: 5.191

8.  First Report of OXA-4, an ESBL Isolated from Pseudomonas aeruginosa a South Indian Strain.

Authors:  S A Jemima Kingsley; Susan Verghese
Journal:  Indian J Microbiol       Date:  2012-10-31       Impact factor: 2.461

9.  Prevalence, microbiology, and clinical characteristics of extended-spectrum beta-lactamase-producing Enterobacter spp., Serratia marcescens, Citrobacter freundii, and Morganella morganii in Korea.

Authors:  S-H Choi; J E Lee; S J Park; M-N Kim; E J Choo; Y G Kwak; J-Y Jeong; J H Woo; N J Kim; Y S Kim
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-08       Impact factor: 3.267

10.  CTX-M-14 β-lactamase-producing Citrobacter freundii isolated in Venezuela.

Authors:  Beatriz Millán; Bárbara Ghiglione; Tulia Díaz; Gabriel Gutkind; María Araque
Journal:  Ann Clin Microbiol Antimicrob       Date:  2011-05-31       Impact factor: 3.944
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.